參考文獻/References:
[1] 周占國,郭浩山,關濤,等.股骨頭壞死病因的相關因素分析[J].中醫(yī)正骨,2020,32(1):7-10.
[2] 何偉,劉予豪,周馳,等.非手術保髖治療非創(chuàng)傷性股骨頭壞死的臨床研究[J].中國中西醫(yī)結合雜志,2020,40(2):176-181.
[3] ROTH A,BECKMANN J,BOHNDORF K,et al.S3-Guideline non-traumatic adult femoral head necrosis[J].Arch Orthop Trauma Surg,2016,136(2):165-174.
[4] YOON B H,KIM T Y,SHIN I S,et al.Alcohol intake and the risk of osteonecrosis of the femoral head in Japanese populations:a dose-response meta-analysis of case-control studies[J].Clin Rheumatol,2017,36(11):2517-2524.
[5] 陳志偉,王振濤,李泰賢,等.酒精相關性股骨頭壞死的發(fā)病特征分析[J].中醫(yī)正骨,2017,29(12):23-25.
[6] 謝斌,張小磊,王榮田,等.酒精性股骨頭壞死的發(fā)病特點分析[J].中國醫(yī)刊,2015,50(11):48-50.
[7] 李子榮.股骨頭壞死臨床診療規(guī)范[J].中華骨與關節(jié)外科雜志,2015,387(1):1-6.
[8] 中華醫(yī)學會骨科分會顯微修復學組,中國修復重建外科專業(yè)委員會骨缺損及骨壞死學組.成人股骨頭壞死診療標準專家共識(2012年版)[J].中華骨科雜志,2012,32(6):606-610.
[9] SAITO M,UESHIMA K,ISHIDA M,et al.Alcohol-associated osteonecrosis of the femoral head with subsequent development in the contralateral hip:a report of two cases[J].J Orthop Sci,2016,21(6):870-874.
[10] 張恩景,廖文,蔡進奎,等.非創(chuàng)傷性股骨頭壞死的基因多態(tài)性研究進展[J].中國骨質疏松雜志,2018,24(4):543-546.
[11] KANEKO S,TAKEGAMI Y,SEKI T,et al.Surgery trends for osteonecrosis of the femoral head:a fifteen-year multi-centre study in Japan[J].Int Orthop,2020,44(4):761-769.
[12] KANG J S,PARK S,SONG J H,et al.Prevalence of osteonecrosis of the femoral head:a nationwide epidemiologic analysis in Korea[J].J Arthroplasty,2009,24(8):1178-1183.
[13] CUI L,ZHUANG Q,LIN J,et al.Multicentric epidemiologic study on six thousand three hundred and ninety five cases of femoral head osteonecrosis in China[J].Int Orthop,2016,40(2):267-276.
[14] SONG Y,DU Z,REN M,et al.Significant associations of SOX9 gene polymorphism and gene expression with the risk of osteonecrosis of the femoral head in a Han population in northern China[J/OL].Biomed Res Int,2016[2020-02-01].https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5174161.
[15] 王秋霞,史傳道,張高魁,等.基于股骨頭壞死數據庫分析成人股骨頭壞死誤診相關因素[J].臨床誤診誤治,2020,33(2):4-9.
[16] 趙巖,沈計榮,張超,等.股骨頭壞死保髖手術治療現狀[J].中醫(yī)正骨,2020,32(1):47-50.
[17] YANG S Y,ZENG L Y,LI C,et al.Correlation between an ABO blood group and primary femoral head necrosis:a case-control study[J].Orthop Surg,2020,12(2):450-456.
[18] LARSON E,JONES L C,GOODMAN S B,et al.Early-stage osteonecrosis of the femoral head:where are we and where are we going in year 2018?[J].Int Orthop,2018,42(7, SI):1723-1728.
[19] 范亞楠,李文龍,張穎,等.不同病因股骨頭壞死的ARCO分期和中日友好醫(yī)院分型特征研究[J].中醫(yī)正骨,2020,32(1):25-27.
[20] 許珂,宇文星,宋夢歌,等.股骨頭壞死全髖關節(jié)置換術患者的人群特征與臨床特點分析[J].中醫(yī)正骨,2020,32(1):51-55.
[21] YOON B H,JONES L C,CHEN C H,et al.Etiologic classification criteria of ARCO on femoral head osteonecrosis part 2:alcohol-associated osteonecrosis[J].J Arthroplasty,2019,34(1):169-174.
[22] 閆洪雨.哈爾濱市區(qū)龍江產白酒市場現狀及質量研究[D].哈爾濱:黑龍江大學,2014.
[23] 劉回春.白酒價格幾元到千元區(qū)別究竟在哪里[J].中國質量萬里行,2016(10):37-38.
[24] LIN Z,LIN Y S.Identification of potential crucial genes associated with steroid-induced necrosis of femoral head based on gene expression profile[J].Gene,2017,627:322-326.
[25] LIU C,AN F M,CAO Y,et al.Significant association between RETN genetic polymorphisms and alcohol-induced osteonecrosis of femoral head[J].Mol Genet Genomic Med,2019,7(8):e822.
相似文獻/References:
[1]陳雷雷,張穎.何偉教授采用中醫(yī)藥療法治療股骨頭壞死的經驗[J].中醫(yī)正骨,2015,27(10):74.
[2]徐西林,趙永蘭,張曉峰,等.活骨注射液髖關節(jié)腔灌注對兔股骨頭壞死模型
血管內皮生長因子表達的動態(tài)影響[J].中醫(yī)正骨,2015,27(08):1.
XU Xilin,ZHAO Yonglan,ZHANG Xiaofeng,et al.Dynamic effect of intra-articular hip injection of Huogu injection on the expression of vascular endothelial growth factor in rabbit models with femur head necrosis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(09):1.
[3]周勇,任菲菲,豐凡翔,等.血管內皮生長因子和骨形態(tài)發(fā)生蛋白2
在非創(chuàng)傷性股骨頭壞死不同區(qū)域的表達[J].中醫(yī)正骨,2015,27(08):7.
ZHOU Yong,REN Feifei,FENG Fanxiang,et al.Expressions of vascular endothelial growth factor and bone morphogenetic protein 2 in different zones of femoral head with non-traumatic osteonecrosis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(09):7.
[4]鮑榮華,王國平,夏曉斌,等.鉭棒植入治療非創(chuàng)傷性股骨頭壞死的療效觀察[J].中醫(yī)正骨,2015,27(02):28.
[5]張兵,馬凰富,劉波,等.非創(chuàng)傷性股骨頭壞死的舌象定量研究[J].中醫(yī)正骨,2015,27(04):8.
ZHANG Bing,MA Huangfu,LIU Bo,et al.Quantitative study on tongue manifestation of patients with nontraumatic osteonecrosis of femoral head[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(09):8.
[6]李剛,程春生.股骨頭壞死血瘀證癥狀與平樂郭氏正骨方藥藥物組成
最大頻繁關聯(lián)模式挖掘[J].中醫(yī)正骨,2015,27(04):21.
LI Gang,CHENG Chunsheng.Maximal frequent association pattern mining for studying the relationship between BLOOD STASIS syndrome in patients with osteonecrosis of femoral head and drug components of Pingle Guo's orthopedics prescription[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(09):21.
[7]李文龍,梅沉成,杜貴強,等.微創(chuàng)減壓植骨多孔鉭棒植入治療
ARCOⅡ期非創(chuàng)傷性缺血性股骨頭壞死[J].中醫(yī)正骨,2016,28(02):43.
[8]張磊,金紅婷,童培建.骨健口服液早期干預非創(chuàng)傷性股骨頭壞死的臨床研究[J].中醫(yī)正骨,2016,28(03):14.
ZHANG Lei,JIN Hongting,TONG Peijian.Clinical study on Gujian Koufuye(骨健口服液)for early intervention of nontraumatic osteonecrosis of femoral head[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2016,28(09):14.
[9]鮑榮華,王國平,夏曉斌,等.直接前入路微創(chuàng)全髖關節(jié)置換術治療晚期股骨頭壞死[J].中醫(yī)正骨,2016,28(03):61.
[10]張超,姚晨,沈計榮.微創(chuàng)髓芯減壓打壓支撐植骨術結合補腎活血湯口服治療ARCOⅡ、Ⅲ期股骨頭壞死的近期療效觀察[J].中醫(yī)正骨,2016,28(03):20.
ZHANG Chao,YAO Chen,SHEN Jirong.[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2016,28(09):20.